Biomarker for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular markers for both metabolic syndrome and hypoglycemia response
  • Genetic lifestyle interaction in the development and prevention of diabetes

Related Conference of Biomarker for Diabetes

July 17-18, 2017

18th European Diabetes Congress

Lisbon, Portugal
July 20-22, 2017

19thAsia Pacific Diabetes Conference

Melbourne, Australia
July 24-26,2017

10th Diabetologists Conference

Vancouver, Canada
September 11-12, 2017

9th Annual Congress on Endocrine Disorders and Therapies


(10 Plenary Forums - 1 Event)
Dallas, Texas, USA
September 20-22, 2017

International Conference on Diabetes

Charlotte, North Carolina, USA
October 02-04, 2017

Diabetes and Endocrinology Congress

Osaka, Japan
November 16-17, 2017

Diabetes, Metabolism & Obesity

Las Vegas, USA
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
December 11-12, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany

Biomarker for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in